Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Doh Yu Hwang, Soo-Jeong Kim, June-Won Cheong, Yundeok Kim, Ji Eun Jang, Jung Yeon Lee, Yoo Hong Min, Woo Ick Yang & Jin Seok Kim. (2016) High pre-transplant serum ferritin and busulfan-thiotepa conditioning regimen as risk factors for hepatic sinusoidal obstructive syndrome after autologous stem cell transplantation in patients with malignant lymphoma. Leukemia & Lymphoma 57:1, pages 51-57.
Read now
Read now
Junya Kanda, Hiroshi Kawabata & Nelson J Chao. (2011) Iron overload and allogeneic hematopoietic stem-cell transplantation. Expert Review of Hematology 4:1, pages 71-80.
Read now
Read now
Sule Unal, Baris Kuskonmaz, Tuncay Hazirolan, Gonca Eldem, Selin Aytac, Mualla Cetin, Duygu Uckan & Fatma Gumruk. (2010) DEFERASIROX USE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PEDIATRIC PATIENTS WITH β-THALASSEMIA MAJOR: Preliminary Results. Pediatric Hematology and Oncology 27:6, pages 482-489.
Read now
Read now
Articles from other publishers (45)
Jaspar Kloehn, Grit Brodt, Jana Ernst & Bernd Gruhn. (2021) Analysis of risk factors for hepatic sinusoidal obstruction syndrome following allogeneic hematopoietic stem cell transplantation in pediatric patients. Journal of Cancer Research and Clinical Oncology 148:6, pages 1447-1455.
Crossref
Crossref
Funda T. Kupesiz, Cigdem Sivrice, Aysenur Akinel, Gulen T. Kintrup, Elif Guler & Alphan Kupesiz. (2022) Efficacy and Safety of Iron Chelation Therapy After Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Thalassemia Patients: A Retrospective Observational Study. Journal of Pediatric Hematology/Oncology 44:1, pages e26-e34.
Crossref
Crossref
Shun Koyamaishi, Takuya Kamio, Akie Kobayashi, Tomohiko Sato, Ko Kudo, Shinya Sasaki, Rika Kanezaki, Daiichiro Hasegawa, Hideki Muramatsu, Yoshiyuki Takahashi, Yoji Sasahara, Hidefumi Hiramatsu, Harumi Kakuda, Miyuki Tanaka, Masataka Ishimura, Masanori Nishi, Akira Ishiguro, Hiromasa Yabe, Takeo Sarashina, Masaki Yamamoto, Yuki Yuza, Nobuyuki Hyakuna, Kenichi Yoshida, Hitoshi Kanno, Shouichi Ohga, Akira Ohara, Seiji Kojima, Satoru Miyano, Seishi Ogawa, Tsutomu Toki, Kiminori Terui & Etsuro Ito. (2020) Reduced-intensity conditioning is effective for hematopoietic stem cell transplantation in young pediatric patients with Diamond–Blackfan anemia. Bone Marrow Transplantation 56:5, pages 1013-1020.
Crossref
Crossref
Asta Salmi, Miia Holmström, Sanna Toiviainen‐Salo, Jukka Kanerva & Mervi Taskinen. (2020) Iron overload after allogeneic stem cell transplantation in children with acute lymphoblastic leukemia. Pediatric Transplantation 24:8.
Crossref
Crossref
Ignacio Gómez-Centurión, Rebeca Bailén, Gillen Oarbeascoa, Cristina Muñoz, Arturo Álvarez Luque, Miguel Echenagusia Boyra, Enrique Calleja, Diego Rincón, Nieves Dorado, Paola Barzallo, Javier Anguita, José Luis Díez-Martín & Mi Kwon. (2020) Transjugular Intrahepatic Portosystemic Shunt for Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-transplantation Cyclophosphamide. Biology of Blood and Marrow Transplantation 26:11, pages 2089-2097.
Crossref
Crossref
Sunita Nathan & Celalettin Ustun. (2019) Complications of Stem Cell Transplantation that Affect Infections in Stem Cell Transplant Recipients, with Analogies to Patients with Hematologic Malignancies. Infectious Disease Clinics of North America 33:2, pages 331-359.
Crossref
Crossref
Chien-Chang Lee, Hsiu-Hao Chang, Meng-Yao Lu, Yung-Li Yang, Shu-Wei Chou, Dong-Tsamn Lin, Shiann-Tarng Jou, Ming Yao, Chi-Cheng Li, Su-Peng Yeh, Mei-Hui Chen, Jyh-Pyng Gau, Sin-Syue Li, Po-Nan Wang, Yi-Chang Liu, Tso-Fu Wang, Tran-Der Tan, Ming-Yang Lee, Ming-Sun Yu, Chuan-Cheng Wang, Shih-Chiang Lin, Yeu-Chin Chen, Yung-Cheng Su, Ko-Ying Su & Kai-Hsin Lin. (2019) The incidence and risk factors of hepatic veno-occlusive disease after hematopoietic stem cell transplantation in Taiwan. Annals of Hematology 98:3, pages 745-752.
Crossref
Crossref
Mairéad Ní Chonghaile & Karen Wolownik. (2018) Identification and Management: Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease Eelated to Hematopoietic Stem Cell Transplantation
. Clinical Journal of Oncology Nursing 22:1, pages E7-E17.
Crossref
Crossref
Bora Kim, Ji Won Lee, Kyung Taek Hong, Kyung-Sang Yu, In-Jin Jang, Kyung Duk Park, Hee Young Shin, Hyo Seop Ahn, Joo-Youn Cho & Hyoung Jin Kang. (2017) Pharmacometabolomics for predicting variable busulfan exposure in paediatric haematopoietic stem cell transplantation patients. Scientific Reports 7:1.
Crossref
Crossref
Serdar Sivgin, Mehmet Fatih Karamustafaoglu, Esra Yildizhan, Gokmen Zararsiz, Leylagul Kaynar, Bulent Eser, Mustafa Cetin & Ali Unal. (2016) The Prognostic Significance of Elevated Serum Ferritin Levels Prior to Transplantation in Patients With Lymphoma Who Underwent Autologous Hematopoietic Stem Cell Transplantation (autoHSCT): Role of Iron Overload. Clinical Lymphoma Myeloma and Leukemia 16, pages S152-S158.
Crossref
Crossref
M Mohty, F Malard, M Abecassis, E Aerts, A S Alaskar, M Aljurf, M Arat, P Bader, F Baron, A Bazarbachi, D Blaise, F Ciceri, S Corbacioglu, J-H Dalle, F Dignan, T Fukuda, A Huynh, T Masszi, M Michallet, A Nagler, M NiChonghaile, S Okamoto, A Pagliuca, C Peters, F B Petersen, P G Richardson, T Ruutu, B N Savani, E Wallhult, I Yakoub-Agha, R F Duarte & E Carreras. (2016) Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation. Bone Marrow Transplantation 51:7, pages 906-912.
Crossref
Crossref
Jean-Hugues Dalle & Sergio A. Giralt. (2016) Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation: Risk Factors and Stratification, Prophylaxis, and Treatment. Biology of Blood and Marrow Transplantation 22:3, pages 400-409.
Crossref
Crossref
Atsushi Kikuta & Kimikazu Yakushijin. (2016) Diagnosis and Treatment of Sinusoidal obstruction syndrome (Veno-occlusive disease) after Haematopoietic cell transplantation. Journal of Hematopoietic Cell Transplantation 5:4, pages 124-137.
Crossref
Crossref
Michaela Döring, Karin Melanie Cabanillas Stanchi, Judith Feucht, Manon Queudeville, Heiko-Manuel Teltschik, Peter Lang, Tobias Feuchtinger, Rupert Handgretinger & Ingo Müller. (2015) Ferritin as an early marker of graft rejection after allogeneic hematopoietic stem cell transplantation in pediatric patients. Annals of Hematology 95:2, pages 311-323.
Crossref
Crossref
Justin M. Asquith, Jessica Copacia, Mark J. Mogul & Rajinder P. S. Bajwa. (2015) Successful use of reduced-intensity conditioning and matched-unrelated hematopoietic stem cell transplant in a child with Diamond-Blackfan anemia and cirrhosis. Pediatric Transplantation 19:6, pages E157-E159.
Crossref
Crossref
N. Maximova, G. Ferrara, M. Minute, A. Pizzol, V. Kiren, M. Montico, M. Gregori & P. Tamaro. (2014) Experience from a single paediatric transplant centre with identification of some protective and risk factors concerning the development of hepatic veno-occlusive disease in children after allogeneic hematopoietic stem cell transplant. International Journal of Hematology 99:6, pages 766-772.
Crossref
Crossref
Bryan J. Trottier, Linda J. Burns, Todd E. DeFor, Sarah Cooley & Navneet S. Majhail. (2013) Association of iron overload with allogeneic hematopoietic cell transplantation outcomes: a prospective cohort study using R2-MRI–measured liver iron content. Blood 122:9, pages 1678-1684.
Crossref
Crossref
M. Großekatthöfer, E. D. Güclü, A. Lawitschka, S. Matthes-Martin, G. Mann, M. Minkov, C. Peters & M. G. Seidel. (2013) Ferritin concentrations correlate to outcome of hematopoietic stem cell transplantation but do not serve as biomarker of graft-versus-host disease. Annals of Hematology 92:8, pages 1121-1128.
Crossref
Crossref
Glen A. Kennedy, Kirk L. Morris, Elango Subramonpillai, Cameron Curley, Jason Butler & Simon Durrant. (2013)
A prospective phase
II
randomized study of deferasirox to prevent iatrogenic iron overload in patients undertaking induction/consolidation chemotherapy for acute myeloid leukaemia
. British Journal of Haematology 161:6, pages 794-801.
Crossref
Crossref
Ji Won Lee, Hyoung Jin Kang, Ji-Yeob Choi, Nam Hee Kim, Mi Kyung Jang, Chang-Woo Yeo, Sang Seop Lee, Hyery Kim, June Dong Park, Kyung Duk Park, Hee Young Shin, Jae-Gook Shin & Hyo Seop Ahn. (2013) Pharmacogenetic Study of Deferasirox, an Iron Chelating Agent. PLoS ONE 8:5, pages e64114.
Crossref
Crossref
Serdar Sivgin & Bulent Eser. (2013) The management of iron overload in allogeneic hematopoietic stem cell transplant (alloHSCT) recipients: Where do we stand?. Annals of Hematology 92:5, pages 577-586.
Crossref
Crossref
Elisabeth C. Sosa. (2012) Veno-Occlusive Disease in Hematopoietic Stem Cell Transplantation Recipients. Clinical Journal of Oncology Nursing 16:5, pages 507-513.
Crossref
Crossref
Philippe Armand, Marie‐Michele Sainvil, Haesook T. Kim, Joanna Rhodes, Corey Cutler, Vincent T. Ho, John Koreth, Edwin P. Alyea, Ellis J. Neufeld, Raymond Y. Kwong, Robert J. Soiffer & Joseph H. Antin. (2012) Does iron overload really matter in stem cell transplantation?. American Journal of Hematology 87:6, pages 569-572.
Crossref
Crossref
Serdar Sivgin, Bulent Eser, Sami Bahcebasi, Leylagul Kaynar, Fatih Kurnaz, Elmas Uzer, Cigdem Pala, Kemal Deniz, Ahmet Ozturk, Mustafa Cetin & Ali Unal. (2011) Efficacy and safety of oral deferasirox treatment in the posttransplant period for patients who have undergone allogeneic hematopoietic stem cell transplantation (alloHSCT). Annals of Hematology 91:5, pages 743-749.
Crossref
Crossref
Z. A. YEGIN, H. PAŞAOĞLU, Ş. Z. AKI, Z. N. ÖZKURT, C. DEMIRTAŞ, M. YAĞCI, K. ACAR & G. T. SUCAK. (2011) Pro-oxidative/antioxidative imbalance: a key indicator of adverse outcome in hematopoietic stem cell transplantation. International Journal of Laboratory Hematology 33:4, pages 414-423.
Crossref
Crossref
Philippe Armand, Haesook T. Kim, Joanna Rhodes, Marie-Michele Sainvil, Corey Cutler, Vincent T. Ho, John Koreth, Edwin P. Alyea, Doreen Hearsey, Ellis J. Neufeld, Mark D. Fleming, Hanno Steen, Damon Anderson, Raymond Y. Kwong, Robert J. Soiffer & Joseph H. Antin. (2011) Iron Overload in Patients with Acute Leukemia or MDS Undergoing Myeloablative Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 17:6, pages 852-860.
Crossref
Crossref
Nancy Bunin, Virginia Guzikowski, Elizabeth R. Rand, Samuel Goldfarb, Jorge Baluarte, Kevin Meyers & Kim M. Olthoff. (2010) Solid organ transplants following hematopoietic stem cell transplant in children. Pediatric Transplantation 14:8, pages 1030-1035.
Crossref
Crossref
E Ozyilmaz, M Aydogdu, G Sucak, S Z Aki, Z N Ozkurt, Z A Yegin & N Kokturk. (2010) Risk factors for fungal pulmonary infections in hematopoietic stem cell transplantation recipients: the role of iron overload. Bone Marrow Transplantation 45:10, pages 1528-1533.
Crossref
Crossref
S H Lee, K H Yoo, K W Sung, H H Koo, Y J Kwon, M M Kwon, H J Park, B-K Park, Y Y Kim, J A Park, H J Im, J J Seo, H J Kang, H Y Shin & H S Ahn. (2009) Hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation: incidence, risk factors, and outcome. Bone Marrow Transplantation 45:8, pages 1287-1293.
Crossref
Crossref
G.T. Sucak, Z.A. Yegin, Z.N. Özkurt, Ş.Z. Akı & M. Yağci. (2010) Iron Overload: Predictor of Adverse Outcome in Hematopoietic Stem Cell Transplantation. Transplantation Proceedings 42:5, pages 1841-1848.
Crossref
Crossref
Z.Y. Lim, V. Fiaccadori, S. Gandhi, J. Hayden, M. Kenyon, R. Ireland, J. Marsh, A.Y.L. Ho, G.J. Mufti & A. Pagliuca. (2010) Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantation. Leukemia Research 34:6, pages 723-727.
Crossref
Crossref
Navneet S. Majhail, Hillard M. Lazarus & Linda J. Burns. (2010) A Prospective Study of Iron Overload Management in Allogeneic Hematopoietic Cell Transplantation Survivors. Biology of Blood and Marrow Transplantation 16:6, pages 832-837.
Crossref
Crossref
J W Lee, H J Kang, E K Kim, H Kim, H Y Shin & H S Ahn. (2009) Effect of iron overload and iron-chelating therapy on allogeneic hematopoietic SCT in children. Bone Marrow Transplantation 44:12, pages 793-797.
Crossref
Crossref
Barbara Cappelli, Robert Chiesa, Costanza Evangelio, Alessandra Biffi, Tito Roccia, Ilaria Frugnoli, Erika Biral, Anna Noè, Marco Fossati, Valentina Finizio, Roberto Miniero, Sara Napolitano, Francesca Ferrua, Clara Soliman, Fabio Ciceri, Maria G. Roncarolo & Sarah Marktel. (2009) Absence of VOD in paediatric thalassaemic HSCT recipients using defibrotide prophylaxis and intravenous Busulphan. British Journal of Haematology 147:4, pages 554-560.
Crossref
Crossref
Simone Cunha Maradei, Angelo Maiolino, Alexandre Mello de Azevedo, Marta Colares, Luis Fernando Bouzas & Marcio Nucci. (2009) Serum ferritin as risk factor for sinusoidal obstruction syndrome of the liver in patients undergoing hematopoietic stem cell transplantation. Blood 114:6, pages 1270-1275.
Crossref
Crossref
Junya Kanda, Chisaki Mizumoto, Hiroshi Kawabata, Tatsuo Ichinohe, Hideyuki Tsuchida, Naohisa Tomosugi, Keitaro Matsuo, Kouhei Yamashita, Tadakazu Kondo, Takayuki Ishikawa & Takashi Uchiyama. (2009) Clinical Significance of Serum Hepcidin Levels on Early Infectious Complications in Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 15:8, pages 956-962.
Crossref
Crossref
Keisuke Kataoka, Yasuhito Nannya, Akira Hangaishi, Yoichi Imai, Shigeru Chiba, Tsuyoshi Takahashi & Mineo Kurokawa. (2009) Influence of Pretransplantation Serum Ferritin on Nonrelapse Mortality after Myeloablative and Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 15:2, pages 195-204.
Crossref
Crossref
V Pullarkat, S Blanchard, B Tegtmeier, A Dagis, K Patane, J Ito & S J Forman. (2008) Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation 42:12, pages 799-805.
Crossref
Crossref
N S Majhail, H M Lazarus & L J Burns. (2008) Iron overload in hematopoietic cell transplantation. Bone Marrow Transplantation 41:12, pages 997-1003.
Crossref
Crossref
J Bouligand, A Le Maitre, D Valteau-Couanet, J Grill, L Drouard-Troalen, A Paci, O Hartmann, E Benhamou & G Vassal. (2007) Elevated Plasma Ferritin and Busulfan Pharmacodynamics During High-dose Chemotherapy Regimens in Children with Malignant Solid Tumors. Clinical Pharmacology & Therapeutics 82:4, pages 402-409.
Crossref
Crossref
Sean R. Bulley, Brigitte Strahm, John Doyle & L. Lee Dupuis. (2007) Defibrotide for the treatment of hepatic veno-occlusive disease in children. Pediatric Blood & Cancer 48:7, pages 700-704.
Crossref
Crossref
Philippe Armand, Haesook T. Kim, Corey S. Cutler, Vincent T. Ho, John Koreth, Edwin P. Alyea, Robert J. Soiffer & Joseph H. Antin. (2007) Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood 109:10, pages 4586-4588.
Crossref
Crossref
A R Kallianpur, L D Hall, M Yadav, D W Byrne, T Speroff, R S Dittus, J L Haines, B W Christman & M L Summar. (2005) The hemochromatosis C282Y allele: a risk factor for hepatic veno-occlusive disease after hematopoietic stem cell transplantation. Bone Marrow Transplantation 35:12, pages 1155-1164.
Crossref
Crossref
A R Kallianpur. (2004) Genomic screening and complications of hematopoietic stem cell transplantation: has the time come?. Bone Marrow Transplantation 35:1, pages 1-16.
Crossref
Crossref
A M Evens, J Mehta & L I Gordon. (2004) Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress. Bone Marrow Transplantation 34:7, pages 561-571.
Crossref
Crossref